Clinical trial
SASL Swiss Cirrhosis Cohort Study
NCT06092385 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SASL Swiss Cirrhosis Cohort Study
- Lead sponsor
- University Hospital, Basel, Switzerland
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 4, 2024
- Completion date
- January 31, 2033
- Enrollment
- 3,000 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.